Today's Date
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
(
BESTT
)
ITN Protocol #:
ITN023ST
Branded Name:
BESTT
ClinicalTrials.Gov ID:
NCT00346151Treatment Protocol #:
Lea29Y
Therapeutic Area:
Transplantation
Current Status:
Complete
Summary:
The Safety and Efficacy of Belatacept, Antithymocyte Globulin, and Sirolimus in Recipients of Non-HLA-identical Living-donor Renal Transplants
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Scientist
PPD Lead Monitor
Study Personnel:
